About Fusion Biotech
Fusion Biotech is a company based in Ulsan (South Korea) founded in 2019 by Chaekyu Kim. Fusion Biotech offers products and services including Fusion Protein-Drug Conjugates, Fusion Nanotherapeutics, and Fusion Protein Therapeutics.
- Headquarter Ulsan, South Korea
- Founders Chaekyu Kim
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name (주)퓨전바이오텍
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fusion Biotech
Fusion Biotech offers a comprehensive portfolio of products and services, including Fusion Protein-Drug Conjugates, Fusion Nanotherapeutics, and Fusion Protein Therapeutics.
Platform for targeted drug delivery to treat diseases effectively
Advanced targeted nano drug complexes for enhanced therapy
Long-lasting bio better proteins for sustained treatment
Funding Insights of Fusion Biotech
Detailed funding history for Fusion Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fusion Biotech
Investment portfolio details for Fusion Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fusion Biotech
Detailed financials for Fusion Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fusion Biotech Comparisons
Peer comparison for Fusion Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fusion Biotech
Detailed competitors of Fusion Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fusion Biotech
Complete news archive for Fusion Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fusion Biotech
Fusion Biotech was founded in 2019.
Fusion Biotech is headquartered in Ulsan, South Korea.
Fusion Biotech was founded in 2019 in Ulsan, South Korea, within the biotechnology sector. Protein-based drugs are developed by the company to address degenerative and intractable diseases. Technology enabling drugs to dock with fusion proteins has been established, supporting therapeutic advancements. Operations center on research and drug development, with a focus on innovative protein fusion applications in healthcare.
Fusion Biotech offers Fusion Protein-Drug Conjugates, Fusion Nanotherapeutics, and Fusion Protein Therapeutics.